# Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study

> **NCT06951685** · NA · RECRUITING · sponsor: **Xeltis** · enrollment: 6 (estimated)

## Conditions studied

- Peripheral Artery Occlusive Disease

## Interventions

- **DEVICE:** Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit

## Key facts

- **NCT ID:** NCT06951685
- **Lead sponsor:** Xeltis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-02
- **Primary completion:** 2026-09
- **Final completion:** 2028-09
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06951685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06951685, "Xeltis Peripheral Artery Disease (XPAD) Bypass Conduit Early Feasibility Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06951685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*